OsNovum Updates
Below are progress updates and information we’ve disseminated through our newsletter. Feel free to click through the updates and don’t forget to subscribe!
New Methods of Diagnosing Who Will Suffer a Bone Fracture
01 February 2021
The current method of screening for risk of a fragility fracture is a dual-energy X-ray absorptiometry scan commonly referred to as DXA…
OsNovum Reduces Inflammation and Outperforms the Competition
28 January 2021
The results are in and we are very proud to share the results of our first major FDA study for OsNovum!
OsNovum Nearing $150K in Funding
19 January 2021
OsNovum has reached a milestone that will allow us to complete our submission and clearance with the FDA…
Exploring the Financial Future
09 December 2020
When treating a patient, you must put aside any bias or dogma and honestly critique how your patient responds to therapy…
The Story of OsNovum and a Funding Milestone
24 November 2020
SteinerBio began the research to introduce its technology for the treatment of failing bones due to osteoporosis in 2016…
Proud Member of:
Tissue Engineering and Regenerative Medicine International Society (TERMIS)
American Society for Bone and Mineral Research (ASBMR)